Listing contains 128 trial(s)
Leukemia, Acute Lymphoblastic, Adult (ALL)
Phase II/III
A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophlaxis After HLA Matched Related Peripheral Blood Stem Cell Transplantation (BMT CTN 0402) Study Number: 07-038 |
Leukemia, Acute Myeloid, Adult (AML)
Phase II/III
A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects with Hematologic Malignancies following Myeloablative Therapy Study Number: 08-070 |
Lymphoma, Non-Hodgkin's Disease, Adult
Phase II
A Phase II Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell Lymphoma following Autologous Peripheral Blood Stem Cell Transplantation (CT-2007-01) Study Number: 07-165 |
Multiple Myeloma / Plasma Cell Neoplasms
Phase III
Randomized Phase 3b Study of Three Treatment Regimens in Subjects with Previously Untreated Multiple Myeloma Who Are Not Considered Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation: VELCADE ¿ (Bortezomib), Thalidomide, and Dexamethasone (VTD) versus VELCADE ¿ and Dexamethasone (VD) versus VELCADE ¿, Melphalan, and Prednisone (VMP) Study Number: 07-059 |
Phase IV
A Randomized Clinical Trial of Lenalidomide (CC-5013) and Dexamethasone With and Without Autologous Peripheral Blood Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma Study Number: 07-134 |
Multiple or All Malignancies (NCI All Types)
Lab
National Marrow Donor Program Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation Study Number: 03-053 |
